BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26037416)

  • 1. Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2.
    Shimada T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Shimada T; Sawamoto K; Miyamoto K; Kitagawa H; Ohta T; Tamai I; Sai Y
    J Pharm Sci; 2015 Sep; 104(9):3162-9. PubMed ID: 26037416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells.
    Hioki M; Shimada T; Yuan T; Nakanishi T; Tajima H; Yamazaki M; Yokono R; Takabayashi M; Sawamoto K; Akashita G; Miyamoto KI; Ohta T; Tamai I; Shimada T; Sai Y
    Biopharm Drug Dispos; 2018 May; 39(5):256-264. PubMed ID: 29682747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
    Ward JL; Sherali A; Mo ZP; Tse CM
    J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
    Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
    Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconstitution in proteoliposomes.
    Mani RS; Hammond JR; Marjan JM; Graham KA; Young JD; Baldwin SA; Cass CE
    J Biol Chem; 1998 Nov; 273(46):30818-25. PubMed ID: 9804860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nucleoside transport systems in cultured rat epididymal epithelium.
    Leung GP; Ward JL; Wong PY; Tse CM
    Am J Physiol Cell Physiol; 2001 May; 280(5):C1076-82. PubMed ID: 11287319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.
    Burke T; Lee S; Ferguson PJ; Hammond JR
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1333-40. PubMed ID: 9732397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
    Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
    Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
    Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
    Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
    Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
    Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
    Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) is Not a Selective Inhibitor of Equilibrative Nucleoside Transporters but Also Blocks Efflux Activity of Breast Cancer Resistance Protein.
    Karbanova S; Sorf A; Jiraskova L; Lalinska A; Ptackova Z; Staud F; Cerveny L
    Pharm Res; 2020 Feb; 37(3):58. PubMed ID: 32086630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
    Vyas S; Ahmadi B; Hammond JR
    Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
    Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.